Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2011
01/04/2011CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/2010
12/30/2010US20100331545 Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient
12/30/2010US20100331380 Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
12/30/2010US20100331370 Novel isobenzofuran analogs of sclerophytin A
12/30/2010US20100331367 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
12/30/2010US20100331346 Beta-amino acid derivatives for treatment of diabetes
12/30/2010US20100331342 Immuno Inhibitory Pyrazolone Compounds
12/30/2010US20100331341 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
12/30/2010US20100331335 Inhibitors of Jun N-Terminal Kinase
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331317 Benzodiazepine compound and pharmaceutical composition
12/30/2010US20100331315 Rhodanines and related heterocycles as kinase inhibitors
12/30/2010US20100331308 Oxazolidinone derivatives
12/30/2010US20100331307 Therapeutic compounds and compositions
12/30/2010US20100331303 Prolyl hydroxylase inhibitors and methods of use
12/30/2010US20100331298 Carboxamide Compounds and Their Use
12/30/2010US20100330685 Diaminorhodamine derivative
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/29/2010WO2010150192A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/29/2010WO2010149326A1 Acid-labile trigger units
12/29/2010WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
12/29/2010EP2266986A1 Cytotoxins, Prodrugs, Linkers and Stabilizers useful therefor
12/29/2010EP2266983A1 Nitrogenated 5-membered heterocyclic compound
12/29/2010EP2266978A1 Novel physiologically active substances
12/29/2010EP2266977A1 2,4-di[(hetero)arylamino]-pyrimidine derivatives as zap-70 and/or syk inhibitors
12/29/2010EP2266976A1 Fused ring thrombin receptor antagonists
12/29/2010EP2266975A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
12/29/2010EP2266973A1 Pyrazinylpyrazole
12/29/2010EP2266970A1 Substituted aromatic heterocyclic compounds as fungicides
12/29/2010EP2266965A1 Methods for Isolating Crystalline Form I of 5-Azacytidine
12/29/2010EP2266964A1 Acid-labile trigger units
12/29/2010EP2266958A1 Antiviral agent
12/29/2010EP2265592A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides
12/29/2010EP2265587A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
12/29/2010EP2265585A1 Amine and ether compounds which modulate the cb2 receptor
12/29/2010EP2265335A1 Indazole derivatives
12/29/2010EP2265273A1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
12/29/2010EP2265271A1 Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP2185512B1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
12/29/2010EP2010514B1 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides
12/29/2010EP1940826B1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
12/29/2010EP1861377B1 Benzimidazolone derivatives as cb2 receptor ligands
12/29/2010EP1791830B1 Diaminotriazole compounds useful as protein kinase inhibitors
12/29/2010EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/29/2010CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/29/2010CN101928282A Preparing method of pyridine compound
12/29/2010CN101928281A Bicyclo-substituted pyrazolone azo derivative, preparation method thereof and application thereof in medicaments
12/29/2010CN101928280A Pepperphentonamine derivative containing naphthalene rings
12/29/2010CN101928279A 3-amino-2-pyrones cyclooxygenase inhibitors as well as preparation method and application thereof
12/29/2010CN101928274A Peperphentonamine derivative
12/29/2010CN101928244A Structural analogue and derivative of isochromanone-4 compound with cardiovascular activity, preparation method and application thereof
12/29/2010CN101928243A Acenaphtho heterocyclic compounds, and cyclodextrin inclusion compounds or conjugates thereof and application thereof in preparing Bcl-2 family protein inhibitors
12/29/2010CN101445504B Dioxane-2-alkyl carbamates derivatives
12/29/2010CN101391994B Synthetic method of itraconazole key intermediate triazole compounds
12/29/2010CN101200465B Decahydronaphthalene compounds and medical uses thereof
12/29/2010CN101142193B Propane-1,3-dion derivative or salt thereof
12/29/2010CA2766320A1 Acid-labile trigger units
12/29/2010CA2766104A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/28/2010USRE42015 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
12/28/2010US7858794 such as 5-Chloro-thiophene-2-carboxylic acid (1-acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide, having follicle stimulating hormone modulatory activity, used to regulate fertility as contraceptives and for treatment of breast cancer, prostate cancer and endometriosis
12/28/2010US7858792 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma
12/28/2010US7858789 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines
12/28/2010US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
12/28/2010US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
12/28/2010US7858657 treating lung cancer with PI-3 kinase inhibitor acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta ,12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta [ alpha ]phenanthren-11-yl ester
12/28/2010US7858644 administering prostaglandin receptor antagonists such as N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide, used analgesics, neuroprtectants and diuretics, or for the treament of diabetes, tinitus, cancer, bone, blood, sleep, cardiovascular and sexual disorders
12/28/2010US7858642 Substituted hydroxyethylamine aspartyl protease inhibitors
12/28/2010US7858633 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/28/2010US7858632 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine
12/28/2010US7858629 3-{(3S)-4-{[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl}-3 -[(isopropylamino)carbonyl]-1-piperazinyl}-1-naphthoic acid, useful for the treatment, control, or prevention of obesity and diabetes
12/28/2010US7858624 such as methyl 2-((R)-((R)-1-((2S,3S)-5-(butylamino)-1-cyclohexyl-3-hydroxy-5-oxopentan-2-ylcarbamoyl)piperidin-3-yl)(3-chlorophenyl)methoxy)ethylcarbamate, used as hypotensive agents or for the treatment of cardiovascular disorders, vision defects, aldosteronism and obesity
12/23/2010WO2010148209A2 Preparation of montelukast
12/23/2010WO2010147922A1 Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
12/23/2010WO2010147898A2 Small molecule inhibitors of spleen tyrosine kinase (syk)
12/23/2010WO2010147791A1 Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
12/23/2010WO2010147430A2 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same
12/23/2010WO2010147375A2 Method for screening for substance which inhibits interaction between beta amyloid peptide and vegf and inhibitor searched by same
12/23/2010WO2010146488A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators
12/23/2010WO2010146173A1 Quinazoline derivatives as histamine h4-recept0r inhibitors for use in the treatment of inflammatory disorders
12/23/2010WO2010146116A1 Triazole compounds carrying a sulfur substituent
12/23/2010WO2010146115A1 Triazole compounds carrying a sulfur substituent
12/23/2010WO2010146114A1 Triazole compounds carrying a sulfur substituent
12/23/2010WO2010145989A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
12/23/2010WO2010145764A1 Substituted enamino carbonyl compounds
12/23/2010WO2010144959A1 Analogues of anti-fibrotic agents
12/23/2010WO2010128528A3 Piperidine derivatives useful for treatment of diebetes
12/23/2010WO2010072770A3 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
12/23/2010WO2009146555A8 Hiv integrase inhibitors from pyridoxine
12/23/2010US20100324296 Dichroic-photochromic compounds and devices
12/23/2010US20100324266 Photocleavable Protecting Groups
12/23/2010US20100324128 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof
12/23/2010US20100324094 Conformationally Restrained Epothilone Analogues as Anti-Leukemic Agents
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324053 Trisubstituted 1,2,4 triazoles
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 694